REAGAN MORGAN: Open Payments
NPI 1295413805 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,226 in 55 payments from 12 companies in 2025. Trend: 2023 $1,092 · 2024 $3,444 · 2025 $2,226
Food & beverage: $2,157Education: $69
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $646 |
| Arcutis Biotherapeutics, Inc. | 10 | $421 |
| Novartis Pharmaceuticals Corporation | 7 | $211 |
| Regeneron Healthcare Solutions, Inc. | 7 | $202 |
| Organon LLC | 6 | $184 |
| Galderma Laboratories, L.P. | 6 | $175 |
| Botanix SB Inc | 1 | $142 |
| Janssen Biotech, Inc. | 2 | $88 |
| ABBVIE INC. | 4 | $82 |
| LEO Pharma Inc. | 1 | $31 |
Products named: DUPIXENT, Zoryve, SOFDRA, VTAMA, NEMLUVIO, TREMFYA, RINVOQ, Rhapsido.
Industry payments across GA — which companies pay providers there.
